The R. rickettsii IFA - IgG marker on a Rickettsiosis panel is a crucial diagnostic tool for identifying infection with Rickettsia rickettsii, the bacterium responsible for Rocky Mountain spotted fever (RMSF), a potentially severe tick-borne illness. This serological test detects Immunoglobulin G (IgG) antibodies that the immune system produces specifically in response to an R. rickettsii infection. IgG antibodies are part of the body's later immune response, typically developing a few weeks after initial exposure to the pathogen and potentially persisting for years, thus indicating either past exposure or chronic infection. The R. rickettsii IFA (Indirect Fluorescent Antibody) - IgG test utilizes the principle of indirect fluorescence, where patient serum is incubated with antigen slides containing R. rickettsii organisms. If IgG antibodies specific to R. rickettsii are present, they bind to these antigens, and this binding is visualized using a fluorescently-labeled anti-human IgG secondary antibody. The presence and intensity of fluorescence, observed under a specialized microscope, provide qualitative and semi-quantitative data about the antibody levels. A positive result is indicative of a past or recent infection but should be interpreted cautiously as IgG antibodies can persist long after the infection has resolved and may cross-react with other Rickettsia species. Moreover, a single positive test result is not sufficient for diagnosis; confirmation typically requires a significant rise in antibody titers in samples taken several weeks apart. Thus, the R. rickettsii IFA - IgG test is a valuable component in diagnosing RMSF, but it should be considered alongside clinical symptoms, patient history, and possibly other diagnostic methods for an accurate and comprehensive assessment of the infection status.
--------------
An "Indeterminate" result (if result falls in orange reference range) in the R. rickettsii IFA - IgG test indicates that the detected levels of IgG antibodies against Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever (RMSF), are unclear and do not conclusively fall within the defined positive or negative ranges. This ambiguous result can be due to several reasons. It might suggest that the antibody levels are at a borderline range, possibly indicating an early immune response where the antibodies are just starting to develop and have not reached a level high enough to be considered positive. Alternatively, it could be a sign of declining antibody levels from a past infection that is resolving or has already resolved, where the antibodies are present but at diminishing levels. An indeterminate result can also arise from technical issues in the test procedure or cross-reactivity with antibodies from other similar infections. In such cases, further evaluation is necessary, often including a clinical assessment of symptoms, patient history, and possibly additional diagnostic tests, such as a repeat IgG test after some time or other serological tests like IgM testing. This indeterminate outcome highlights the complexity of diagnosing RMSF based solely on serological testing and underscores the importance of a comprehensive clinical assessment to accurately determine the infection status.
R. rickettsii IFA - IgG
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.